Peripheral Artery Disease (PAD) Clinical Trial
Official title:
Vascular Physician Offer and Report (VAPOR) Trial
The purpose of the study is to see if vascular physicians (your provider) using a combination
of proven smoking cessation tools in an organized way can help vascular patients quit smoking
better than usual.
The doctors where you are being treated have been chosen to either provide:
the combination therapy of giving you advice, considering prescribing medications to help you
quit smoking, and referring you to a phone quitline, or to continue their usual smoking
cessation practices (which may include all, some, or none of the treatments above).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02227368 -
Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
|
Phase 2 | |
| Completed |
NCT03744572 -
Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
|
||
| Recruiting |
NCT06052319 -
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
|
||
| Recruiting |
NCT05941533 -
Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease
|
||
| Active, not recruiting |
NCT02924857 -
The Chocolate Touch Study
|
N/A | |
| Not yet recruiting |
NCT05665816 -
Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
|
||
| Active, not recruiting |
NCT04821388 -
Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries
|
N/A | |
| Recruiting |
NCT03304821 -
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
|
Phase 2 |